Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines

Clinical and Vaccine Immunology

Volumn 13, Issue 2, 2006, Pages 165-169

  Romero Steiner, Sandra ^a   Frasch, Carl E ^b   Carlone, George ^a   Fleck, Roland A ^c   Goldblatt, David ^d   Nahm, Moon H ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLHYDROCUPREINE; IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE; SPECTINOMYCIN; STREPTOMYCIN; TRIMETHOPRIM;

ANTIBODY TITER; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL KILLING; CELL VIABILITY; CLINICAL TRIAL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNOGENICITY; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; SEROLOGY; SHORT SURVEY; STREPTOCOCCUS INFECTION; VALIDATION PROCESS;

ANIMALS; ANTIBODIES, BACTERIAL; CELL LINE; HUMANS; OPSONIN PROTEINS; PHAGOCYTOSIS; PNEUMOCOCCAL VACCINES;

EID: 33644905553     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.13.2.165-169.2006     Document Type: Short Survey

References (17)

1. Bieging, K., G. Rajam, P. Holder, R. Udoff, G. M. Carlone, and S. Romero-Steiner. 2005. Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 12:1238-1242.
2. Bogaert, D., M. Sluijter, R. De Groot, and P. W. Hermans. 2004. Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine. Vaccine 22:4014-4020.
3. Fleck, R. A., S. Romero-Steiner, and M. H. Nahm. 2005. Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies. A review. Clin. Diagn. Lab. Immunol. 12:19-27.
4. Hu, B. T., X. Yu, T. R. Jones, C. Kirch, S. Harris, S. W. Hildreth, D. V. Madore, and S. A. Quataert. 2005. Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 12:287-295.
5. Jodar, L., J. C. Butler, G. Carlone, R. Dagan, C. E. Frasch, D. Goldblatt, H. Käyhty, K. Klugman, B. D. Plikaytis, G. Siber, R. Kohberger, I. Chang, and T. Cherian. 2003. Serological criteria for evaluation and licensure of pneumococcal conjugate vaccine formulations for use in infants. Vaccine 21:3265-3272.
6. Kim, K. H., J. Yu, and M. H. Nahm. 2003. Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies. Clin. Diagn. Lab. Immunol. 10:616-621.
7. Lindholm, N., H. Lehtonen, T. Kilpi, H. Ahman, H. Kayhty, and T. F. S. group. 2002. Functional activity of antibodies for pneumococcal (Pnc) type 6B and 19F polysaccharides after immunization with the Pnc conjugate vaccine PncCRM in the Finnish Oititer Media (FinOM) vaccine trial, p. 85. ISPPD meeting abstract, ISPPD-3, Anchorage, Alaska.
8. Liu, X., S. Wang, L. Sendi, and M. J. Caulfield. 2004. High-throughput imaging of bacterial colonies grown on filter plates with application to serum bactericidal assays. J. Immunol. Methods 292:187-193.
9. Madhi, S. A., L. Kuwanda, C. Cutland, A. Holm, H. Kayhty, and K. P. Klugman. 2005. Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children. Pediatr. Infect. Dis. J. 24:410-416.
10. Martinez, J. E., S. Romero-Steiner, T. Pilishvili, S. Barnard, J. Schinsky, D. Goldblatt, and G. M. Carlone. 1999. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin. Diagn. Lab. Immunol. 6:581-586.
11. Nahm, M. H., D. E. Briles, and X. Yu. 2000. Development of a multispecificity opsonophagocytic killing assay. Vaccine 18:2768-2771.
12. Nurkka, A., J. Joensuu, I. Henckaerts, P. Peeters, J. Poolman, T. Kilpi, and H. Kayhty. 2004. Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants. Pediatr. Infect. Dis. J. 23:1008-1014.
13. Plikaytis, B. D., D. Goldblatt, C. E. Frasch, C. Blondeau, M. J. Bybel, G. S. Giebink, I. Jonsdottir, H. Kayhty, H. B. Konradsen, D. V. Madore, M. H. Nahm, C. A. Schulman, P. F. Holder, T. Lezhava, C. M. Elie, and G. M. Carlone. 2000. An analytical model applied to a multicenter pneumococcal ELISA study. J. Clin. Microbiol. 38:2043-2050.
14. Romero-Steiner, S., C. Frasch, N. Concepcion, D. Goldblatt, H. Kayhty, M. Vakevainen, C. Laferriere, D. Wauters, M. H. Nahm, M. F. Schinsky, B. D. Plikaytis, and G. M. Carlone. 2003. Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 10:1019-1024.
15. Romero-Steiner, S., D. Libutti, L. B. Pais, J. Dykes, P. Anderson, J. C. Whitin, H. L. Keyserling, and G. M. Carlone. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
16. Vakevainen, M., W. Jansen, E. Saeland, I. Jonsdottir, H. Snippe, A. Verheul, and H. Kayhty. 2001. Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable? Clin. Diagn. Lab. Immunol. 8:363-369.
17. Wernette, C. M., C. E. Frasch, D. Madore, G. Carlone, D. Goldblatt, B. Plikaytis, W. Benjamin, S. A. Quataert, S. Hildreth, D. J. Sikkema, H. Kayhty, I. Jonsdottir, and M. H. Nahm. 2003. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin. Diagn. Lab. Immunol. 10:514-519.